Objectives: Our objective was to evaluate the trend and to assess the impact of maternal region of residence in Western New York (WNY), on severe neonatal opioid withdrawal syndrome (NOWS).
Study Design: Term infants' born at gestational age greater than or equal to 37 weeks with severe NOWS, defined as withdrawal resulting in the receipt of pharmacologic therapy from WNY admitted to our neonatal intensive care unit (NICU) from January 1, 2008 to December 31, 2016, were included. Severe NOWS admissions to our NICU from the following five regions were controlled with birth and insurance data: (1) Urban North, (2) Erie Coastal, (3) Niagara Frontier, (4) Southern Tier, and (5) Urban South.
Results: "Urban South" residence was associated with an increased risk of severe NOWS (adjusted odds ratio = 1.8, 97.5% confidence interval: 1.1-2.9). The trend in admission for severe NOWS doubled between 2008 to 2010 and 2014 to 2016 ( = 0.01). More infants born to maternal nonprescribed opioid users were placed in foster care at discharge (36.5 vs. 1.9%, < 0.001).
Conclusion: In WNY, neonates born to mothers from the "Urban South" were twice at risk of being admitted for severe NOWS. One-third of infants with severe NOWS after nonprescribed opioid use were placed in foster care. Implementing targeted strategies at the community level may help improve outcomes in NOWS.
Key Points: · Maternal region of residence is a risk factor for severe neonatal opioid withdrawal.. · Admissions for severe neonatal opioid withdrawal trended up from 2008 to 2010 to 2014 to 2016.. · One-third of the infants born to mothers on nonprescribed opioids were discharged to foster care..
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/a-1925-1659 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The acoustic properties, syllable structure, and syllable sequences of ultrasonic vocalizations (USVs) during neonatal opioid withdrawal in FVB/N mouse substrains.
bioRxiv
November 2024
Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA USA.
Concomitant with the opioid epidemic, there has been a rise in pregnant women diagnosed with opioid use disorder and cases of infants born with neonatal opioid withdrawal syndrome (NOWS). NOWS refers to signs and symptoms following cessation of prenatal opioid exposure that comprise neurological, gastrointestinal, and autonomic system dysfunction. A critical indicator of NOWS severity is excessive, high-pitched crying.
View Article and Find Full Text PDFIllicit Fentanyl in the Prenatal Period: A Significant Emerging Risk for Neonatal Opioid Withdrawal Syndrome.
Am J Perinatol
October 2024
Division of Neonatology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.
Article Synopsis
- This study assessed the effects of in-utero exposure to illicit fentanyl on neonatal outcomes, focusing on conditions like neonatal opioid withdrawal syndrome (NOWS), length of stay (LOS), and treatment needs.
- Conducted from March 2020 to December 2022, the research found that nearly half of the infants in the study had in-utero fentanyl exposure, linked to characteristics such as older maternal age and lower prenatal care.
- Results indicated that fentanyl exposure significantly increased the likelihood and severity of NOWS, necessitated earlier treatment, and was associated with longer hospital stays for both preterm and full-term neonates.
Prenatal Substance Exposure and Infant Discharge Placement: Results From the ACT NOW Study.
Child Maltreat
October 2024
Department of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Article Synopsis
- Researchers need to find out what factors might put babies at risk of being taken out of their homes, especially due to their parents' substance use.
- In a study with 1,808 parent-baby pairs, most of the parents were Non-Hispanic White, and many babies were exposed to drugs like alcohol and opioids before birth.
- The study found that many babies with drug exposure didn't get to go home with their parents, and understanding how substance use affects placement decisions can help improve support for families in need.
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice.
Psychopharmacology (Berl)
September 2024
Laboratory of Addiction Genetics, Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, 140 The Fenway, Boston, MA, USA.
Article Synopsis
- Opioid use during pregnancy can cause serious health issues for infants, like neonatal opioid withdrawal syndrome (NOWS), which involves various dysfunctions that require tailored treatment approaches.* -
- A study on neonatal mice revealed increased ultrasonic vocalizations (USVs) during opioid withdrawal, with significant behavioral and mRNA changes associated with kappa opioid receptors implicated in stress responses.* -
- Findings suggest that the kappa opioid receptor plays a critical role in withdrawal-related distress, particularly in female mice, highlighting variations in USV patterns and responses in males and females during this process.*
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?
Am J Addict
January 2025
University of Poitiers, Poitiers, France.
Article Synopsis
- Neonatal opioid withdrawal syndrome (NOWS) occurs in infants after exposure to opioids during pregnancy, with buprenorphine often used for treatment in mothers.
- A study analyzed data from 75 term newborns treated for NOWS in neonatal intensive care units, finding that higher doses of maternal buprenorphine correlated with longer withdrawal durations and more severe symptoms.
- The research suggests that increasing doses of buprenorphine during pregnancy leads to more severe NOWS, indicating a need for further exploration of dosing practices to improve outcomes for affected infants.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!